Published in J Mol Histol on September 21, 2007
TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression. Biotechnol Bioeng (2009) 0.86
An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform. ACS Chem Biol (2011) 0.80
Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake. J Virol (2015) 0.78
Control of cell fate decisions. J Mol Histol (2007) 0.76
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
Cellular uptake of the tat protein from human immunodeficiency virus. Cell (1988) 10.19
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell (1991) 8.99
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48
Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell (1988) 5.26
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc Natl Acad Sci U S A (1991) 4.66
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A (2002) 4.22
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol (1992) 3.41
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem (2000) 2.98
Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A (1996) 2.65
Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J (1991) 2.62
Chlorate--a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun (1986) 2.57
Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem (2005) 2.46
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem (2003) 2.23
Tyrosine sulfation is a trans-Golgi-specific protein modification. J Cell Biol (1987) 2.10
Tumor formation dependent on proteoglycan biosynthesis. Science (1988) 2.04
Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol (2004) 1.93
Genetic analysis of proteoglycan structure, function and metabolism. Curr Opin Cell Biol (1991) 1.93
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem (1993) 1.92
Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng (2006) 1.89
The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry (2005) 1.87
Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development (1999) 1.86
Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev (1996) 1.77
Purification and characterization of heparin lyases from Flavobacterium heparinum. J Biol Chem (1992) 1.77
Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science (1993) 1.67
Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis. J Biol Chem (1991) 1.65
Heparan sulfate: lessons from knockout mice. J Clin Invest (2001) 1.56
Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J Cell Biol (2003) 1.55
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem (2003) 1.53
Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein. Virology (1988) 1.52
Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J (2004) 1.45
Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta (2002) 1.42
Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem (1999) 1.42
Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J Biol Chem (2002) 1.41
Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res (1999) 1.38
PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes (2003) 1.34
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem (1997) 1.32
Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun (2000) 1.29
Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure. J Biol Chem (1994) 1.29
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol (2004) 1.23
Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J Biol Chem (1988) 1.10
Protein transduction: an alternative to genetic intervention? Gene Ther (2001) 1.08
BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes (2005) 1.05
Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun (2003) 1.04
Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum. Appl Environ Microbiol (1996) 1.04
Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem (1995) 0.99
Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. J Cell Physiol (2002) 0.98
Protein transduction technology: a novel therapeutic perspective. Acta Med Okayama (2006) 0.96
Heparin binding by the HIV-1 tat protein transduction domain. Protein Sci (2001) 0.96
Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development. Dev Dyn (2003) 0.95
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp Cell Res (2005) 0.94
Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells. Cancer Res (1982) 0.93
Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem (1992) 0.92
Chondroitin sulfate in palatal wound healing. J Dent Res (2004) 0.89
Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products. Glycobiology (2004) 0.88
Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity. FASEB J (1998) 0.88
A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. Development (1996) 0.85
Heparan sulphate proteoglycans and spinal neurulation in the mouse embryo. Development (2002) 0.84
Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes. Arch Biochem Biophys (1995) 0.84
Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from beta-D-xyloside inhibition of proliferation. Arch Biochem Biophys (1992) 0.83
Biosynthesis and properties of a further member of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem (1990) 0.83
TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death. J Neurochem (2005) 0.83
Herpes simplex virus: discovering the link between heparan sulphate and hereditary bone tumours. Rev Med Virol (2000) 0.82
Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2alpha pathway in human osteoblastic MG63 cells. J Biochem (2004) 0.81
The effect of beta-D-xylosides on the proliferation and proteoglycan biosynthesis of monoblastic U-937 cells. Biochem J (1990) 0.81
Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans. Diabetologia (2007) 0.79
Chlorate-induced inhibition of tyrosine sulfation on bone sialoprotein synthesized by a rat osteoblast-like cell line (UMR 106-01 BSP). J Biol Chem (1994) 0.79
Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Res (1999) 0.79
Removal of proteoglycans increases efficiency of retroviral gene transfer. Biotechnol Bioeng (1998) 0.79
Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells. J Med Microbiol (2004) 0.78
Measurement of the anchorage force between GPI-anchored alkaline phosphatase and supported membranes by AFM force spectroscopy. Langmuir (2005) 0.78
Sulfated oligosaccharides and tumor: promoter or inhibitor? Panminerva Med (2006) 0.76
Delivering information-rich drugs--prospects and challenges. Trends Biotechnol (1996) 0.75
Proteoglycan gene targeting in somatic cells. Methods Mol Biol (2001) 0.75
Significant role of adhesion properties of primary osteoblast-like cells in early adhesion events for chondroitin sulfate and dermatan sulfate surface molecules. J Biomed Mater Res (1999) 0.75
Beta-D-xyloside induced modulations of glycosaminoglycans, proliferation, and cytoskeletal organization of rat liver myofibroblast-like cells (transformed fat storing cells). Cell Mol Biol (1991) 0.75
Modulation of sulfated glycosaminoglycan and small proteoglycan synthesis by the extracellular matrix. Mol Cell Biochem (2000) 0.75
Wnt signaling controls the fate of mesenchymal stem cells. Gene (2008) 1.92
Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface. Structure (2013) 1.59
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials (2005) 1.42
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells (2008) 1.37
Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res (2008) 1.35
Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res (2011) 1.30
Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules (2008) 1.28
Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene (2003) 1.25
Phylogeny of the Infraorder Pentatomomorpha based on fossil and extant morphology, with description of a new fossil family from China. PLoS One (2012) 1.19
Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther (2011) 1.15
FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling. J Cell Physiol (2010) 1.14
Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial-derived tissues. Genesis (2003) 1.13
Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets (2004) 1.11
Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cells (2007) 1.09
Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma. Mol Biol Rep (2008) 1.09
Reduced seminal parameters associated with environmental DDT exposure and p,p'-DDE concentrations in men in Chiapas, Mexico: a cross-sectional study. J Androl (2006) 1.09
A simple and reliable electroporation method for human bone marrow mesenchymal stem cells. Stem Cells Dev (2008) 1.07
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials (2010) 1.07
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res (2010) 1.05
Substrate induction of osteogenesis from marrow-derived mesenchymal precursors. Stem Cells Dev (2005) 1.05
The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials (2011) 1.05
Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone (2011) 1.04
Heparan sulfate regulation of progenitor cell fate. J Cell Biochem (2006) 1.04
Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials (2012) 1.03
High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells. J Cell Biochem (2014) 1.03
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem (2013) 1.01
Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS One (2007) 1.01
Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene (2006) 1.00
Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev (2011) 0.99
The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts. J Cell Biochem (2009) 0.99
Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev (2009) 0.99
Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. Tissue Eng Part C Methods (2010) 0.97
Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1). J Cell Physiol (2009) 0.97
Telomere length analysis of human mesenchymal stem cells by quantitative PCR. Gene (2013) 0.97
Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway. J Biol Chem (2010) 0.96
Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol (2007) 0.95
Identification of valid housekeeping genes and antioxidant enzyme gene expression change in the aging rat liver. J Gerontol A Biol Sci Med Sci (2006) 0.93
The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials (2009) 0.93
Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells. J Cell Physiol (2006) 0.92
Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci (2004) 0.91
TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx. J Leukoc Biol (2005) 0.91
Isolation of a native osteoblast matrix with a specific affinity for BMP2. J Mol Histol (2007) 0.90
The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol (2009) 0.90
Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J Mol Histol (2007) 0.89
Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model. J Mol Histol (2007) 0.89
Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol (2006) 0.88
Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochem J (2003) 0.88
The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cells. J Mol Histol (2007) 0.86
Role of growth hormone receptor signaling in osteogenesis from murine bone marrow progenitor cells. Biochem Biophys Res Commun (2005) 0.86
The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. Acta Biomater (2013) 0.86
Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev (2007) 0.86
The osteoblast-heparan sulfate axis: control of the bone cell lineage. Int J Biochem Cell Biol (2005) 0.85
Heparan sulfate control of proliferation and differentiation in the stem cell niche. Crit Rev Eukaryot Gene Expr (2007) 0.85
Adult CNS explants as a source of neural progenitors. Brain Res Brain Res Protoc (2005) 0.83
Glycosaminoglycans modulate RANKL-induced osteoclastogenesis. J Cell Biochem (2010) 0.83
Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow. Stem Cells Dev (2012) 0.83
Gelation of helical polypeptide-random coil diblock copolymers by a nanoribbon mechanism. Angew Chem Int Ed Engl (2005) 0.82
Surface area characterization of obliquely deposited metal oxide nanostructured thin films. Langmuir (2010) 0.82
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem (2014) 0.82
Persistent TNF-alpha exposure impairs store operated calcium influx in CD4+ T lymphocytes. FEBS Lett (2005) 0.82
The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells. Pharm Res (2010) 0.82
Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells. Biointerphases (2010) 0.81
The use of heparan sulfate to augment fracture repair in a rat fracture model. J Orthop Res (2006) 0.81
FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1). Stem Cells (2013) 0.81